Us-china Biomedical Technology (CLDS) Return on Equity ROE from the first quarter 2020 to first quarter 2019 and annually, average high and low, overall ranking from May 31 2019 to May 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Us-china Biomedical Technology, Inc.  (CLDS)
    Sector • Services    Industry • Advertising
   Industry • Advertising
   Sector • Services

Us-china Biomedical Technology's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Us-china Biomedical Technology in the first quarter 2020?
Due to the lack of equity, it was not possible to calculate Us-china Biomedical Technology, Inc.'s return on equity (ROE) in its first quarter 2020

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (May 31 2019)
I. Quarter		 (Feb 28 2019)
IV. Quarter		 (Nov 30 2018)
III. Quarter		 (Aug 31 2018)
II. Quarter		 (May 31 2018)
I. Quarter
Y / Y Equity Change -78.71 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1 -1 -1 -1 -1
Return On Equity (TTM) -395.93 % -312.76 % -385.3 % -2064.66 % -
CLDS's Total Ranking # 4313 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 0 0 0 0 0
Seq. Equity Change 6515.05 % -99.2 % -40.49 % -32.66 % -
Seq. Net Income Change - - - - -

Back to CLDS Management Effectiveness >> CLDS's 5 Years Annual ROE >> Compare CLDS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 20
Sector # 505
Overall # 4313

Return On Equity Statistics
High Average Low
-312.76 %
-789.66 %
-2064.66 %
(Feb 28 2019)   (Aug 31 2018)





CLDS Annual Return On Equity (Feb 28 2019)
2019		 (Feb 28 2018)
2018		 (Feb 28 2017)
2017		 (Feb 28 2015)
2015		 (Feb 28 2014)
2014
Total Equity in Millions 0 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -1 0 0 0 -1
Y / Y Net Income Change - - - - -
Return On Equity -50457.06 % - - - -

Back to CLDS Management Effectiveness >> CLDS's 5 Years Annual ROE >> Compare CLDS ROE to its Competitors




More Return On Equity Ratios
Advertising Industry Roe Trends and Statistics
Services Sector Return On Equity Statistics
CLDS's' Return on Equity at Yahoo Finance
CLDS's Roe Ratio versus Advertising Industry, Services Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CLDS's Competitors
Subscribers only: Roe for Us-china Biomedical Technology's Suppliers
Subscribers only: Return On Equity for CLDS's Customers




Companies with similar Return On Equity at May 31 2019, within Services Sector ROE

Date modified: 2026-09-08T15:09:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.